Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands

被引：245
作者：
de Bont, JM
van der Holt, B
Dekker, AW
van der Does-van den Berg, A
Sonneveld, P
Pieters, R
机构：
[1] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Oncol & Hematol, NL-3015 GJ Rotterdam, Netherlands
[2] Erasmus MC, Dr Daniel Den Hoed Canc Ctr, Rotterdam, Netherlands
[3] UMC Utrecht, Utrecht, Netherlands
[4] DCOG, The Hague, Netherlands
来源：
LEUKEMIA | 2004年 / 18卷 / 12期
关键词：
D O I：
10.1038/sj.leu.2403538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2032 / 2035
页数：4
相关论文
共 9 条
  • [1] HIGH-DOSE METHOTREXATE IMPROVES CLINICAL OUTCOME IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - ST-JUDE TOTAL THERAPY STUDY
    ABROMOWITCH, M
    OCHS, J
    PUI, CH
    KALWINSKY, D
    RIVERA, GK
    FAIRCLOUGH, D
    LOOK, AT
    HUSTU, HO
    MURPHY, SB
    EVANS, WE
    DAHL, GV
    BOWMAN, WP
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (05): : 297 - 303
  • [2] Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia
    Aricò, M
    Valsecchi, MG
    Camitta, B
    Schrappe, M
    Chessells, J
    Baruchel, A
    Gaynon, P
    Silverman, L
    Janka-Schaub, G
    Kamps, W
    Pui, CH
    Masera, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) : 998 - 1006
  • [3] Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials
    Boissel, N
    Auclerc, MF
    Lhéritier, V
    Perel, Y
    Thomas, X
    Leblanc, T
    Rousselot, P
    Cayuela, JM
    Gabert, J
    Fegueux, N
    Piguet, C
    Huguet-Rigal, F
    Berthou, C
    Boiron, JM
    Poutos, C
    Michel, G
    Fière, D
    Leverger, G
    Dombret, H
    Baruchel, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) : 774 - 780
  • [4] Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
    Bostrom, BC
    Sensel, MR
    Sather, HN
    Gaynon, PS
    La, MK
    Johnston, K
    Erdmann, GR
    Gold, S
    Heerema, NA
    Hutchinson, RJ
    Provisor, AJ
    Trigg, ME
    [J]. BLOOD, 2003, 101 (10) : 3809 - 3817
  • [5] 6-MERCAPTOPURINE CUMULATIVE DOSE - A CRITICAL FACTOR OF MAINTENANCE THERAPY IN AVERAGE RISK CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    DIBENEDETTO, SP
    GUARDABASSO, V
    RAGUSA, R
    DICATALDO, A
    MIRAGLIA, V
    DAMICO, S
    IPPOLITO, AM
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1994, 11 (03) : 251 - 258
  • [6] Richards S, 1996, LANCET, V347, P1783
  • [7] Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
    Silverman, LB
    Gelber, RD
    Dalton, VK
    Asselin, BL
    Barr, RD
    Clavell, LA
    Hurwitz, CA
    Moghrabi, A
    Samson, Y
    Schorin, MA
    Arkin, S
    Declerck, L
    Cohen, HJ
    Sallan, SE
    [J]. BLOOD, 2001, 97 (05) : 1211 - 1218
  • [8] Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood
    Toyoda, Y
    Manabe, A
    Tsuchida, M
    Hanada, R
    Ikuta, K
    Okimoto, Y
    Ohara, A
    Ohkawa, Y
    Mori, T
    Ishimoto, K
    Sato, T
    Kaneko, T
    Maeda, M
    Koike, K
    Shitara, T
    Hoshi, Y
    Hosoya, R
    Tsunematsu, Y
    Bessho, F
    Nakazawa, S
    Saito, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) : 1508 - 1516
  • [9] Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia
    Weisdorf, DJ
    Billett, AL
    Hannan, P
    Ritz, J
    Sallan, SE
    Steinbuch, M
    Ramsay, NKC
    [J]. BLOOD, 1997, 90 (08) : 2962 - 2968
1